Medfield, MA, United States of America

Mark Puder

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Mark Puder: Innovator in Lung Disease Treatment

Introduction

Mark Puder is a distinguished inventor based in Medfield, MA (US), known for his significant contributions to the field of lung disease treatment. With a total of 14 patents to his name, Puder has made remarkable strides in developing innovative therapies aimed at improving lung health.

Latest Patents

Among his latest patents, Puder has developed ApoM-Fc fusion proteins for treating lung diseases. This invention provides methods for treating lung disease using fusion proteins that comprise ApoM, which can be either human or murine, fused to a constant region of immunoglobulin G (IgG). Additionally, he has described methods and compositions relating to lung repair, focusing on inducing and enhancing lung growth and repair by administering an agonist of sFlt1-Hif signaling to a subject or contacting lung tissue with such an agonist.

Career Highlights

Throughout his career, Mark Puder has worked with notable institutions, including Children's Medical Center Corporation and Beth Israel Deaconess Medical Center, Inc. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Kathleen Marie Gura and Bruce R Bistrian, who have played significant roles in his research endeavors.

Conclusion

Mark Puder's innovative work in lung disease treatment exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in therapies that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…